News and Analysis

Icosavax rallies $100m Series B

Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing.

-

Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing. RA Capital Management led the round.

Source: Press Release